|
|
.
See Category: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
See Header: Other specified anemias
ICD-10 (CM) Code and Descriptor
|
D64.81 |
Anemia due to antineoplastic chemotherapy
|
D6481 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 11.54%
|
15.56%
|
17.90%
|
15.28%
|
11.59%
|
7.96%
|
5.73%
|
3.87%
|
2.64%
|
1.98%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D64.81*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
8,242
|
8,259
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
6,286
|
6,350
|
|
36430
|
TRANSFUSION BLD/BLD COMPNT |
6,274
|
6,279
|
|
86900
|
BLOOD TYPING SEROLOGIC ABO |
5,695
|
5,852
|
|
80053
|
COMPREHEN METABOLIC PANEL |
5,470
|
5,472
|
|
86901
|
BLOOD TYPING SEROLOGIC RH(D) |
5,369
|
5,446
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
4,946
|
5,322
|
|
86850
|
RBC ANTIBODY SCREEN |
4,915
|
5,008
|
|
P9016
|
RBC LEUKOCYTES REDUCED |
4,639
|
6,881
|
|
86923
|
COMPATIBILITY TEST ELECTRIC |
3,290
|
4,507
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,790
|
2,796
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
2,497
|
103,481
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
2,187
|
5,212
|
|
Q5106
|
INJ RETACRIT NON-ESRD USE |
2,075
|
75,374
|
|
86920
|
COMPATIBILITY TEST SPIN |
1,908
|
2,728
|
|
J0881
|
DARBEPOETIN ALFA, NON-ESRD |
1,837
|
539,480
|
|
96413
|
CHEMO IV INFUSION 1 HR |
1,556
|
1,556
|
|
83735
|
ASSAY OF MAGNESIUM |
1,483
|
1,491
|
|
P9040
|
RBC LEUKOREDUCED IRRADIATED |
1,458
|
2,060
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
1,434
|
2,429
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D64.81 related to the following DRG Codes:
811-812
|
